| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab
|
Desai, Kunal
|
|
|
16 |
5 |
p. 633-642
|
artikel
|
| 2 |
A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer
|
Moore, Kathleen N.
|
|
|
16 |
5 |
p. 569-589
|
artikel
|
| 3 |
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study
|
Santoni, Matteo
|
|
|
16 |
5 |
p. 625-632
|
artikel
|
| 4 |
Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
|
Evans, Rachel
|
|
|
16 |
5 |
p. 613-623
|
artikel
|
| 5 |
Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience
|
Rimini, Margherita
|
|
|
16 |
5 |
p. 653-661
|
artikel
|
| 6 |
Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line
|
Fiala, Ondřej
|
|
|
16 |
5 |
p. 643-652
|
artikel
|
| 7 |
Isatuximab: A Review of Its Use in Multiple Myeloma
|
Frampton, James E.
|
|
|
16 |
5 |
p. 675-686
|
artikel
|
| 8 |
Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC
|
Lamb, Yvette N.
|
|
|
16 |
5 |
p. 687-695
|
artikel
|
| 9 |
Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer
|
Wang, Jiani
|
|
|
16 |
5 |
p. 591-599
|
artikel
|
| 10 |
Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice
|
Brufsky, Adam
|
|
|
16 |
5 |
p. 601-611
|
artikel
|
| 11 |
Risk of Infection with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
|
Petrelli, Fausto
|
|
|
16 |
5 |
p. 553-568
|
artikel
|
| 12 |
Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced Differentiation
|
Ramsey, Haley E.
|
|
|
16 |
5 |
p. 663-674
|
artikel
|
| 13 |
The Status of Adjuvant and Neoadjuvant Melanoma Therapy, New Developments and Upcoming Challenges
|
Stege, Henner
|
|
|
16 |
5 |
p. 537-552
|
artikel
|
Tijdschrift beschrijving